Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience2001Chen JF, Xu K, Petzer JP, et al.

Study designOther primary literature

SubjectAnimal

Record checks

Study design: Other primary literature
Subject: Animal
Publication year: 2001
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

MeSH

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine3,4-Dihydroxyphenylacetic AcidAnimalsCaffeineCatecholsCorpus StriatumDisease Models, AnimalDopamineDose-Response Relationship, DrugImmunity, InnateInjections, IntraperitonealMaleMiceMice, Inbred C57BLMice, KnockoutNeuroprotective AgentsParkinsonian DisordersPurinergic P1 Receptor AntagonistsPurinesPyrimidinesReceptor, Adenosine A2AReceptors, Purinergic P1TheobromineTriazolesXanthines

DOI 10.1523/jneurosci.21-10-j0001.2001

PMID 11319241

View source →